Six systems. One outcome: the world recognizes your science.
Each service is productized: defined scope, defined outputs, defined timelines. No vague retainers. No scope creep. Built exclusively for funded biotech founders.
Social Media Management
Multi-platform content calendars built for biotech audiences. We don't just post. We engineer presence on the channels where your investors, scientific peers, and pharma BD teams actually live.
- Platforms managed: LinkedIn, X, Instagram, Facebook, YouTube, and Substack
- Content repurposed across formats, carousels, posts, and short-form video
- Community management and engagement on your behalf
- Monthly analytics report tied to investor and partnership KPIs
Founder + Company LinkedIn Ghostwriting
You're a scientist. You should be running clinical trials, not writing LinkedIn posts. We write in your voice, based on monthly 30-minute strategy calls, and turn your insights into the kind of authority content that gets investors to slide into your DMs.
- 3–4 LinkedIn posts per week, written in your founder and company voice
- Monthly strategy call to capture insights for both profiles
- Investor-aware narrative arc, compounding authority with every post
- Engagement responses drafted and quarterly inbound review
Content Engine
The high-leverage assets that move pharma BD teams to email you, that investors quote in committee meetings, that journalists actually open. Whitepapers, technical case studies, scientific blog posts, all written by people who understand your science.
- Scientific case studies, clinical narratives, and long-form thought leadership
- Founder op-eds placed in Endpoints, Fierce, BioSpace, and KOL interview articles
- Video production and editing across LinkedIn, YouTube, and owned channels
- Webinar hosting, strategy, and post-event content repurposing
SEO Blog Writing
Rank for the queries your buyers actually type. We do keyword research grounded in biotech intent: clinical, technical, regulatory, investor. We ship blog content that earns top-3 positions for terms your competitors haven't even targeted yet.
- 2–4 SEO-optimized blog posts per month
- Biotech-specific keyword research: clinical, technical, and investor intent
- On-page SEO including schema markup, internal links, and semantic optimization
- Quarterly audits, Search Console and GA4 reporting tied to lead generation
GEO / AEO, AI Search Optimization
Investors and BD execs are no longer Googling. They're asking ChatGPT, Perplexity, and Google AI Overviews. These models cite different brands than search engines do. Almost no biotech is optimized for AI search. That's the gap. We close it.
- Golden Prompts audit: how AI models currently describe you (or don't)
- Structured data, llm.txt, and AI-readable content reformatting for citation extraction
- Brand entity engineering across Wikipedia, Wikidata, and knowledge graphs
- Monthly visibility tracking across ChatGPT, Perplexity, Gemini, and Claude
Website Development
Your website is your investor pitch when you're not in the room. We build sites that are scientifically credible, conversion-engineered, and fast, optimized for Core Web Vitals, AI-search readability, and the kind of clarity that gets BD execs to email you within 60 seconds of landing.
- Custom design. No templates, ever.
- Built for Core Web Vitals (LCP, CLS, INP)
- Schema markup, semantic HTML, AI-search ready
- Optional retainer: monthly updates, blog publishing, performance monitoring
Automated Investor & BD Outreach
We're partnering with a best-in-class outreach platform to help biotech founders automate personalised pitching to investors, pharma BD leads, and strategic partners. Reach the right rooms without lifting a finger.
- Hyper-targeted prospecting lists built for your stage and indication
- Personalised multi-touch sequences via email and LinkedIn
- Partner platform integration: automated send, track, and follow-up
- Monthly pipeline report with reply rates and meeting conversion
Start with the audit. We'll tell you.
Our free 30-page diagnostic identifies the highest-leverage starting point for your specific biotech, based on your stage, audience, and current visibility gaps.